HC Wainwright & Co. Maintains Buy on Korro Bio, Lowers Price Target to $100

Benzinga · 05/08 11:10
HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and lowers the price target from $115 to $100.